Valuation Jazz Pharmaceuticals plc

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-04 pm EST			5-day change	1st Jan Change
166.91 ^USD	-0.11%		-5.66%	+35.53%

Dec. 02	Jazz Pharmaceuticals plc to Present Pivotal Phase 3 Results of Ziihera®? (zanidatamab-hrii) Combinations in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma at the 2026 ASCOGastrointestinal Cancers Symposium	CI
Dec. 02	Jazz Pharmaceuticals plc Presents at Citi Annual Global Healthcare Conference 2025, Dec-02-2025 09:45 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	9,196	7,831	10,031	7,744	7,445	10,142	-	-
Change	-	-14.84%	28.09%	-22.8%	-3.86%	36.23%	-	-
Enterprise Value (EV) ¹	10,233	13,290	14,874	11,830	10,561	13,460	12,552	11,163
Change	-	29.88%	11.92%	-20.46%	-10.73%	27.46%	-6.75%	-11.07%
P/E ratio	39.1x	-23.1x	-44.5x	20.2x	14.2x	-26.4x	21.6x	13.6x
PBR	2.53x	1.98x	3.26x	2.05x	1.82x	2.32x	1.87x	1.51x
PEG	-	0x	1.3x	-0x	0.3x	0x	-0x	0.2x
Capitalization / Revenue	3.89x	2.53x	2.74x	2.02x	1.83x	2.4x	2.25x	2.09x
EV / Revenue	4.33x	4.29x	4.06x	3.09x	2.6x	3.18x	2.78x	2.3x
EV / EBITDA	11.1x	9.78x	11.1x	7.04x	6x	22x	6.92x	5.75x
EV / EBIT	11.4x	9.32x	11.4x	7.17x	6.12x	20.7x	6.78x	5.6x
EV / FCF	11.6x	17.7x	12x	11.1x	7.78x	13.3x	8.46x	6.81x
FCF Yield	8.65%	5.65%	8.36%	9.03%	12.9%	7.54%	11.8%	14.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	4.22	-5.52	-3.58	6.1	8.65	-6.324	7.725	12.28
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,364	3,094	3,659	3,834	4,069	4,230	4,517	4,847
EBITDA ¹	917.9	1,359	1,338	1,681	1,760	610.7	1,815	1,941
EBIT ¹	899.3	1,425	1,307	1,650	1,727	650.3	1,852	1,993
Net income ¹	238.6	-329.7	-224.1	414.8	560.1	-411.1	528.9	802.5
Net Debt ¹	1,037	5,458	4,843	4,087	3,116	3,318	2,410	1,021
Reference price ²	165.05	127.40	159.31	123.00	123.15	166.91	166.91	166.91
Nbr of stocks (in thousands)	55,714	61,470	62,966	62,957	60,455	60,765	-	-
Announcement Date	2/23/21	3/1/22	3/1/23	2/28/24	2/25/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
JAZZ PHARMACEUTICALS PLC	-26.42x	3.18x	22.06x	-.--%	10.15B
ELI LILLY AND COMPANY	45.19x	14.94x	33.19x	0.57%	925B
JOHNSON & JOHNSON	19.6x	5.5x	15.21x	2.52%	495B
ABBVIE INC.	53.78x	7.6x	18x	2.83%	407B
ROCHE HOLDING AG	18.2x	4.58x	11.46x	3.15%	335B
ASTRAZENECA PLC	27.53x	5.21x	15.44x	1.77%	283B
NOVARTIS AG	18.52x	5.01x	11.77x	3.05%	257B
MERCK & CO., INC.	13.22x	4.31x	9.21x	3.16%	254B
NOVO NORDISK A/S	13.16x	4.71x	9.78x	3.83%	211B
AMGEN INC.	25.28x	6.35x	10.9x	2.77%	186B
Average	20.80x	6.14x	15.70x	2.36%	336.4B
Weighted average by Cap.	30.51x	8.10x	18.87x	2.2%